Chief Policy Officer Digital Therapeutics Alliance Arlington, Virginia
Disclosure(s):
Megan Coder, PharmD, MBA: No financial relationships to disclose
Digital health products and solutions are rapidly entering the market with the promise of improving access, quality, and outcomes of care - with greater visibility by providers to patient ongoing status and sharing real-time actionable data with individuals to be active participants in their care. Join this session to hear updates from leading experts on current regulatory process for connected sensor products and digital therapeutics - and steps needed to establish coverage for these remote monitoring products and treatment modalities to support deployment at scale.
